These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 15934093)

  • 1. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
    Weidler C; Struharova S; Schmidt M; Ugele B; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Jun; 52(6):1721-9. PubMed ID: 15934093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
    Miller LE; Grifka J; Schölmerich J; Straub RH
    J Rheumatol; 2002 Mar; 29(3):427-35. PubMed ID: 11908553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
    Castagnetta LA; Carruba G; Granata OM; Stefano R; Miele M; Schmidt M; Cutolo M; Straub RH
    J Rheumatol; 2003 Dec; 30(12):2597-605. PubMed ID: 14719200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
    Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
    Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Jun; 52(6):1711-20. PubMed ID: 15934114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between placenta growth factor 1 and vascularization, dehydroepiandrosterone sulfate to dehydroepiandrosterone conversion, or aromatase expression in patients with rheumatoid arthritis and patients with osteoarthritis.
    Lowin T; Weidler C; Jenei-Lanzl Z; Capellino S; Baerwald CG; Buttgereit F; Straub RH
    Arthritis Rheum; 2012 Jun; 64(6):1799-808. PubMed ID: 22170453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
    Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
    Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF and sex hormones.
    Cutolo M; Sulli A; Capellino S; Villaggio B; Montagna P; Pizzorni C; Paolino S; Seriolo B; Felli L; Straub RH
    Ann N Y Acad Sci; 2006 Jun; 1069():391-400. PubMed ID: 16855166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
    Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
    Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokines in different histological variants of rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
    Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
    Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S; Hafström I; Werner S; Carlström K; Tengstrand B
    J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.